ALK‐fusion‐positive non‐small‐cell lung cancer (ALK+ NSCLC) is a distinct molecular subtype of NSCLC characterized by a rearrangement of the anaplastic lymphoma kinase (ALK) gene [1]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.